julia greenstein ph.d.

Dr. Julia Greenstein is a consultant leading Life Science Advisors, consulting for the biotech and academic community as well as in the area of medical and scientific philanthropy. Previously she was Vice President for Research Strategy at Juvenile Diabetes Research Foundation (JDRF), serving in a variety of roles over 12 years beginning in the Beta cell portfolio and in a variety of roles in the Cure and Prevention portfolios. Previously she was CEO of Immerge BioTherapeutics, Inc., a Novartis Pharma/BioTransplant JV focusing on xenotransplantation and supporting the development of a porcine islet transplantation program. She has held the roles CSO at BioTransplant and VP of Discovery Research at ImmuLogic Pharmaceutical Corp. Her time at small biotechnology companies focused on building novel programs and interacting with academic and pharmaceutical company collaborators, as well as, being involved in the financing efforts of these organizations. Both independent companies held their initial public offering with her involvement. She received her PhD in Microbiology from University of Rochester Medical School. She did postdoctoral training at the University of Rochester Medical School and the Dana Farber Cancer Institute of Harvard Medical School and was an Assistant Professor at the Dana Farber Cancer Institute. In addition, she serves on the Board of Directors of Russell Sage College and is on the University of Rochester Regional Cabinet.